The most common of all follies is to believe passionately in the palpably not true. It is the chief occupation of mankind." - H. L. Mencken
Today, we take a look at a small gene therapy concern that just came public a couple of years ago and has an advancing pipeline.
Company Overview:
Tocagen (TOCA) is a San Diego, California-based clinical-stage biopharmaceutical company that IPO'd in early 2017. The company is developing product candidates to treat cancer by leveraging their cancer-selective gene therapy platform, which is built upon retroviral replicating vectors. The